![Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial - The Lancet Respiratory Medicine Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial - The Lancet Respiratory Medicine](https://www.thelancet.com/cms/attachment/555feb8c-fd20-4e05-9612-fd49d29b8273/gr1.gif)
Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial - The Lancet Respiratory Medicine
![Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial - ScienceDirect Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2213260019304175-gr1.gif)
Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial - ScienceDirect
![Clinical trials in acute respiratory distress syndrome: challenges and opportunities - The Lancet Respiratory Medicine Clinical trials in acute respiratory distress syndrome: challenges and opportunities - The Lancet Respiratory Medicine](https://www.thelancet.com/cms/attachment/a0aa07e5-9273-456a-9b23-246a7959b2cf/gr1_lrg.jpg)
Clinical trials in acute respiratory distress syndrome: challenges and opportunities - The Lancet Respiratory Medicine
![Neonatal Respiratory Distress Syndrome Treatment Market Ongoing Research And Development Activities Are Expected To Propel Growth Of The Global Market | Chiesi Farmaceutici S.P.A, JW pharmaceuticals | Medgadget Neonatal Respiratory Distress Syndrome Treatment Market Ongoing Research And Development Activities Are Expected To Propel Growth Of The Global Market | Chiesi Farmaceutici S.P.A, JW pharmaceuticals | Medgadget](https://www.medgadget.com/wp-content/uploads/2022/02/neonatal-respiratory-distress-syndrome-treatment-market-scaled.jpg)
Neonatal Respiratory Distress Syndrome Treatment Market Ongoing Research And Development Activities Are Expected To Propel Growth Of The Global Market | Chiesi Farmaceutici S.P.A, JW pharmaceuticals | Medgadget
Recombinant Human Activated Protein C in the Treatment of Acute Respiratory Distress Syndrome: A Randomized Clinical Trial | PLOS ONE
![Treatment for severe acute respiratory distress syndrome from COVID-19 - The Lancet Respiratory Medicine Treatment for severe acute respiratory distress syndrome from COVID-19 - The Lancet Respiratory Medicine](https://www.thelancet.com/cms/asset/2b7e5bc9-c30b-4853-9e48-11f00bffe02e/gr1.jpg)
Treatment for severe acute respiratory distress syndrome from COVID-19 - The Lancet Respiratory Medicine
![Survival predictors in elderly patients with acute respiratory distress syndrome: a prospective observational cohort study | Scientific Reports Survival predictors in elderly patients with acute respiratory distress syndrome: a prospective observational cohort study | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-018-31811-w/MediaObjects/41598_2018_31811_Fig1_HTML.png)
Survival predictors in elderly patients with acute respiratory distress syndrome: a prospective observational cohort study | Scientific Reports
![Prognosis of acute respiratory distress syndrome in neutropenic cancer patients | European Respiratory Society Prognosis of acute respiratory distress syndrome in neutropenic cancer patients | European Respiratory Society](https://erj.ersjournals.com/content/erj/40/1/169/F1.large.jpg)
Prognosis of acute respiratory distress syndrome in neutropenic cancer patients | European Respiratory Society
![Updated European Consensus Guidelines on Respiratory Distress Syndrome in preterm babies cites 39 Cochrane Reviews | Cochrane Updated European Consensus Guidelines on Respiratory Distress Syndrome in preterm babies cites 39 Cochrane Reviews | Cochrane](https://www.cochrane.org/sites/default/files/public/uploads/news-_headline.png)
Updated European Consensus Guidelines on Respiratory Distress Syndrome in preterm babies cites 39 Cochrane Reviews | Cochrane
![Therapeutic effects and outcomes of rescue high-frequency oscillatory ventilation for premature infants with severe refractory respiratory failure | Scientific Reports Therapeutic effects and outcomes of rescue high-frequency oscillatory ventilation for premature infants with severe refractory respiratory failure | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-021-88231-6/MediaObjects/41598_2021_88231_Fig1_HTML.png)
Therapeutic effects and outcomes of rescue high-frequency oscillatory ventilation for premature infants with severe refractory respiratory failure | Scientific Reports
![Acute Respiratory Distress Syndrome; Acute Hypoxemic Respiratory Failure, Non-Cardiogenic Pulmonary Edema, High-Permeability Pulmonary Edema - Cancer Therapy Advisor Acute Respiratory Distress Syndrome; Acute Hypoxemic Respiratory Failure, Non-Cardiogenic Pulmonary Edema, High-Permeability Pulmonary Edema - Cancer Therapy Advisor](https://www.cancertherapyadvisor.com/wp-content/uploads/sites/12/2019/01/ch423.fig1_.jpg)
Acute Respiratory Distress Syndrome; Acute Hypoxemic Respiratory Failure, Non-Cardiogenic Pulmonary Edema, High-Permeability Pulmonary Edema - Cancer Therapy Advisor
![Effectiveness of prone position in acute respiratory distress syndrome and moderating factors of obesity class and treatment durations for COVID-19 patients: A meta-analysis - ScienceDirect Effectiveness of prone position in acute respiratory distress syndrome and moderating factors of obesity class and treatment durations for COVID-19 patients: A meta-analysis - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S096433972200060X-gr1.jpg)
Effectiveness of prone position in acute respiratory distress syndrome and moderating factors of obesity class and treatment durations for COVID-19 patients: A meta-analysis - ScienceDirect
![Membranes | Free Full-Text | Cumulative Fluid Balance during Extracorporeal Membrane Oxygenation and Mortality in Patients with Acute Respiratory Distress Syndrome Membranes | Free Full-Text | Cumulative Fluid Balance during Extracorporeal Membrane Oxygenation and Mortality in Patients with Acute Respiratory Distress Syndrome](https://www.mdpi.com/membranes/membranes-11-00567/article_deploy/html/images/membranes-11-00567-g001.png)
Membranes | Free Full-Text | Cumulative Fluid Balance during Extracorporeal Membrane Oxygenation and Mortality in Patients with Acute Respiratory Distress Syndrome
![Acute respiratory distress syndrome in adults: diagnosis, outcomes, long-term sequelae, and management - The Lancet Acute respiratory distress syndrome in adults: diagnosis, outcomes, long-term sequelae, and management - The Lancet](https://www.thelancet.com/cms/attachment/ecb20dfe-c1d9-4722-96b3-f47303396095/gr1_lrg.jpg)